Increased Akt-mTOR signaling in lung epithelium is associated with respiratory distress syndrome in mice

Molecular and Cellular Biology

Volumn 31, Issue 5, 2011, Pages 1054-1065

  Ikeda, Hiroyuki ^a,b   Shiojima, Ichiro ^a,c   Oka, Toru ^a,c   Yoshida, Masashi ^a   Maemura, Koji ^d   Walsh, Kenneth ^e   Igarashi, Takashi ^b   Komuro, Issei ^a,c  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 2ALPHA; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; RAPAMYCIN; VASCULOTROPIN;

ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; RESPIRATORY DISTRESS SYNDROME; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFANT, NEWBORN; INSULIN; LUNG; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RESPIRATORY MUCOSA; SIROLIMUS; TOR SERINE-THREONINE KINASES; VASCULAR ENDOTHELIAL GROWTH FACTORS;

MAMMALIA; MUS; MUS MUSCULUS;

EID: 79952265832     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00732-10     Document Type: Article

References (34)

1. Abid, M. R., et al. 2004. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 24:294-300.
2. Bentley-Lewis, R., S. Levkoff, A. Stuebe, and E. W. Seely. 2008. Gestational diabetes mellitus: postpartum opportunities for the diagnosis and prevention of type 2 diabetes mellitus. Nat. Clin. Pract. Endocrinol. Metab. 4:552-558.
3. Clausen, T. D., et al. 2005. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 28:323-328. (Pubitemid 40170934)
4. Compernolle, V., et al. 2002. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat. Med. 8:702-710.
5. Crowther, C. A., et al. 2005. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med. 352:2477-2486.
6. Dave, V., et al. 2006. Calcineurin/Nfat signaling is required for perinatal lung maturation and function. J. Clin. Invest. 116:2597-2609.
7. Dave, V., et al. 2008. Conditional deletion of Pten causes bronchiolar hyperplasia. Am. J. Respir. Cell Mol. Biol. 38:337-345.
8. Dekowski, S. A., and J. M. Snyder. 1992. Insulin regulation of messenger ribonucleic acid for the surfactant-associated proteins in human fetal lung in vitro. Endocrinology 131:669-676.
9. Feig, D. S., and V. A. Palda. 2002. Type 2 diabetes in pregnancy: a growing concern. Lancet 359:1690-1692.
10. Guttentag, S. H., D. S. Phelps, W. Stenzel, J. B. Warshaw, and J. Floros. 1992. Surfactant protein A expression is delayed in fetuses of streptozotocin-treated rats. Am. J. Physiol. 262:L489-L494.
11. Guttentag, S. H., D. S. Phelps, J. B. Warshaw, and J. Floros. 1992. Delayed hydrophobic surfactant protein (SP-B, SP-C) expression in fetuses of streptozotocin-treated rats. Am. J. Respir. Cell Mol. Biol. 7:190-197.
12. Hallman, M., V. Glumoff, and M. Ramet. 2001. Surfactant in respiratory distress syndrome and lung injury. Comp. Biochem. Physiol. Part A 129:287-294.
13. Hudson, C. C., et al. 2002. Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin. Mol. Cell. Biol. 22:7004-7014.
14. Jensen, D. M., et al. 2004. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care 27:2819-2823. (Pubitemid 39565043)
15. Kim, C. F., et al. 2005. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121:823-835. (Pubitemid 40806415)
16. Kim, H. S., et al. 2002. Regulation of angiogenesis by glycogen synthase kinase-3β. J. Biol. Chem. 277:41888-41896.
17. Luukko, K., A. Ylikorkala, M. Tiainen, and T. P. Makela. 1999. Expression of LKB1 and PTEN tumor suppressor genes during mouse embryonic development. Mech. Dev. 83:187-190.
18. Maemura, K., et al. 1999. Generation of a dominant-negative mutant of endothelial PAS domain protein 1 by deletion of a potent C-terminal transactivation domain. J. Biol. Chem. 274:31565-31570.
19. Montan, S., and S. Arulkumaran. 2006. Neonatal respiratory distress syndrome. Lancet 367:1878-1879. (Pubitemid 43831978)
20. Morimoto, M., and R. Kopan. 2009. rtTA toxicity limits the usefulness of the SP-C-rtTA transgenic mouse. Dev. Biol. 325:171-178.
21. Nold, J. L., and M. K. Georgieff. 2004. Infants of diabetic mothers. Pediatr. Clin. North Am. 51:619-637.
22. Northway, W. H., Jr., R. C. Rosan, and D. Y. Porter. 1967. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N. Engl. J. Med. 276:357-368.
23. Perl, A. K., S. E. Wert, A. Nagy, C. G. Lobe, and J. A. Whitsett. 2002. Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc. Natl. Acad. Sci. U. S. A. 99:10482-10487.
24. Shioi, T., et al. 2003. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 107:1664-1670. (Pubitemid 36397337)
25. Shiojima, I., et al. 2005. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest. 115:2108-2118.
26. Shiojima, I., et al. 2002. Akt signaling mediates postnatal heart growth in response to insulin and nutritional status. J. Biol. Chem. 277:37670-37677.
27. Stenmark, K. R., and S. H. Abman. 2005. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu. Rev. Physiol. 67:623-661.
28. Taniguchi, C. M., B. Emanuelli, and C. R. Kahn. 2006. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7:85-96.
29. Tichelaar, J. W., W. Lu, and J. A. Whitsett. 2000. Conditional expression of fibroblast growth factor-7 in the developing and mature lung. J. Biol. Chem. 275:11858-11864.
30. Warburton, D., et al. 2000. The molecular basis of lung morphogenesis. Mech. Dev. 92:55-81.
31. Whitsett, J. A., and T. E. Weaver. 2002. Hydrophobic surfactant proteins in lung function and disease. N. Engl. J. Med. 347:2141-2148.
32. Xue, Q., et al. 2009. Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase. Arterioscler. Thromb. Vasc. Biol. 29:1172-1178.
33. Yanagi, S., et al. 2007. Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J. Clin. Invest. 117:2929-2940.
34. Zhang, Y., et al. 2008. A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration. Nat. Genet. 40:862-870.